Acquisitions, Sale of Hospira Infusion Systems Net Assets, Collaborative Arrangement and Equity-Method Investments - Collaboration Arrangement (Details) - Other (Income)/Deductions, Net [Member] - Merck KGaA [Member] - Collaborative Arrangement [Member] - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Apr. 02, 2017	Oct. 01, 2017
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Upfront payments received	$ 90
Collaborator's revenue and expense ownership percentage		60.00%
Company's revenue and expense ownership percentage		40.00%